Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer
SPIGEL, David R, ERVIN, Thomas J, GOVINDAN, Ramaswamy, PATEL, Taral, ORLOV, Sergey V, WERTHEIM, Michael S, WEI YU, JIPING ZHA, YAUCH, Robert L, PATEL, Premal H, PHAN, See-Chun, PETERSON, Amy C, RAMLAU, Rodryg A, DANIEL, Davey B, GOLDSCHMIDT, Jerome H, BLUMENSCHEIN, George R, KRZAKOWSKI, Maciej J, ROBINET, Gilles, GODBERT, Benoit, BARLESI, Fabrice
Published in Journal of clinical oncology (10.11.2013)
Published in Journal of clinical oncology (10.11.2013)
Get full text
Journal Article
Conference Proceeding
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
Posner, Marshall R, Hershock, Diane M, Blajman, Cesar R, Mickiewicz, Elizabeth, Winquist, Eric, Gorbounova, Vera, Tjulandin, Sergei, Shin, Dong M, Cullen, Kevin, Ervin, Thomas J, Murphy, Barbara A, Raez, Luis E, Cohen, Roger B, Spaulding, Monica, Tishler, Roy B, Roth, Berta, Viroglio, Rosana del Carmen, Venkatesan, Varagur, Romanov, Ilya, Agarwala, Sanjiv, Harter, K. William, Dugan, Matthew, Cmelak, Anthony, Markoe, Arnold M, Read, Paul W, Steinbrenner, Lynn, Colevas, A. Dimitrios, Norris, Charles M, Haddad, Robert I
Published in The New England journal of medicine (25.10.2007)
Published in The New England journal of medicine (25.10.2007)
Get full text
Journal Article
Treatment Rationale and Study Design for a Randomized, Double-Blind, Placebo-Controlled Phase II Study Evaluating Onartuzumab (MetMAb) in Combination With Bevacizumab Plus mFOLFOX-6 in Patients With Previously Untreated Metastatic Colorectal Cancer
Bendell, Johanna C, Ervin, Thomas J, Gallinson, David, Singh, Jaswinder, Wallace, James A, Saleh, Mansoor N, Vallone, Marcy, Phan, See-Chun, Hack, Stephen P
Published in Clinical colorectal cancer (01.09.2013)
Published in Clinical colorectal cancer (01.09.2013)
Get full text
Journal Article
A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-small Cell Lung Cancer
Spigel, David R., Hainsworth, John D., Shipley, Dianna L., Ervin, Thomas J., Kohler, Peter C., Lubiner, Eric T., Peyton, James D., Waterhouse, David M., Burris, Howard A., Greco, F. Anthony
Published in Journal of thoracic oncology (01.01.2012)
Published in Journal of thoracic oncology (01.01.2012)
Get full text
Journal Article
The influence of beam energy on the outcome of postoperative radiotherapy in head and neck cancer patients: secondary analysis of RTOG 85-03
Aref, Amr, Berkey, Brian A, Schwade, James G, Ensley, John, Schuller, David E, Haselow, Robert E, Ervin, Thomas J, Laramore, George E
Published in International journal of radiation oncology, biology, physics (01.05.2000)
Published in International journal of radiation oncology, biology, physics (01.05.2000)
Get full text
Journal Article
A Phase II Trial of Bendamustine, Bortezomib, and Rituximab in Patients with Previously Untreated Low Grade Lymphoma
Flinn, Ian W., Ervin, Thomas J., Boccia, Ralph V., Flora, Douglas B., Cuevas, J. Daniel, Thompson, Dana S., Shipley, Dianna L., Berdeja, Jesus G.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib in combination with rituximab for previously treated indolent non-Hodgkin lymphomas (iNHL)
Salles, Gilles A., Ervin, Thomas J., Dichmann, Robert, Ramchandren, Rod, Page, Ray D., Battini, Ramakrishna, Lawler, William E., Holes, Leanne, Adewoye, Adeboye H., De Vos, Sven
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
A randomized, phase II, multicenter, double-blind, placebo-controlled study evaluating onartuzumab (MetMAb) in combination with mFOLFOX6 plus bevacizumab in patients with metastatic colorectal cancer
Bendell, Johanna C., Ervin, Thomas J., Gallinson, David H., Singh, Jaswinder, Wallace, James Alfred, Saleh, Mansoor N., Vallone, Marcy, Hack, Stephen Paul
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Second interim analysis of a phase 3 study evaluating idelalisib and rituximab for relapsed CLL
Coutre, Steven E., Furman, Richard R., Sharman, Jeff Porter, Cheson, Bruce D., Pagel, John M., Hillmen, Peter, Barrientos, Jacqueline Claudia, Zelenetz, Andrew David, Kipps, Thomas J., Flinn, Ian, Ghia, Paolo, Eradat, Herbert Aaron, Ervin, Thomas J., Lamanna, Nicole, Coiffier, Bertrand, Pettitt, Andrew, Kim, Yeonhee, Jahn, Thomas Michael, O'Brien, Susan Mary, Hallek, Michael J.
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Phase II study of oral idarubicin in favorable histology non-Hodgkin's lymphoma
CASE, D. C, HAYES, D. M, GERBER, M, GAMS, R, ERVIN, T. J, DORSK, B. M
Published in Cancer research (Chicago, Ill.) (01.11.1990)
Get full text
Published in Cancer research (Chicago, Ill.) (01.11.1990)
Journal Article
Results of the X-PECT study: A phase III randomized double-blind, placebo-controlled study of perifosine plus capecitabine (P-CAP) versus placebo plus capecitabine (CAP) in patients (pts) with refractory metastatic colorectal cancer (mCRC)
Bendell, Johanna C., Ervin, Thomas J., Senzer, Neil N., Richards, Donald A., Firdaus, Irfan, Lockhart, A. Craig, Cohn, Allen Lee, Saleh, Mansoor N., Gardner, Lesa R., Sportelli, Peter, Eng, Cathy
Published in Journal of clinical oncology (20.06.2012)
Published in Journal of clinical oncology (20.06.2012)
Get full text
Journal Article
Results of the X-PECT study: A phase III randomized double-blind placebo-controlled study of perifosine plus capecitabine (P-CAP) versus placebo plus capecitabine (CAP) in patients (pts) with refractory metastatic colorectal cancer (mCRC)
Bendell, Johanna C., Ervin, Thomas J., Senzer, Neil N., Richards, Donald A., Firdaus, Irfan, Lockhart, A. Craig, Cohn, Allen Lee, Saleh, Mansoor N., Gardner, Lesa R., Sportelli, Peter, Eng, Cathy
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Results of a randomized phase III trial (MPACT) of weekly nab -paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas with PET and CA19-9 correlates
Von Hoff, Daniel D., Ervin, Thomas J., Arena, Francis P., Chiorean, E. Gabriela, Infante, Jeffrey R., Moore, Malcolm J., Seay, Thomas E., Tjulandin, Sergei, Ma, Wen Wee, Saleh, Mansoor N., Harris, Marion, Reni, Michele, Ramanathan, Ramesh K., Tabernero, Josep, Hidalgo, Manuel, Van Cutsem, Eric, Goldstein, David, Wei, Xinyu, Iglesias, Jose Luis, Renschler, Markus Frederic
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
CA19-9 decrease at 8 weeks as a predictor of overall survival (OS) in a randomized phase III trial (MPACT) of weekly nab -paclitaxel ( nab -P) plus gemcitabine (G) versus G alone in patients with metastatic pancreatic cancer (MPC)
Chiorean, E. Gabriela, Von Hoff, Daniel D., Ervin, Thomas J., Arena, Francis P., Infante, Jeffrey R., Bathini, Venu Gopal, Wood, Tina Evans, Mainwaring, Paul N., Muldoon, Robert T., Clingan, Philip R., Kunzmann, Volker, Ramanathan, Ramesh K., Tabernero, Josep, Goldstein, David, Ko, Amy, Lu, Brian
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Prognostic factors (PFs) of survival in a randomized phase III trial (MPACT) of weekly nab -paclitaxel ( nab -P) plus gemcitabine (G) versus G alone in patients (pts) with metastatic pancreatic cancer (MPC)
Moore, Malcolm J., Von Hoff, Daniel D., Ervin, Thomas J., Arena, Francis P., Chiorean, E. Gabriela, Infante, Jeffrey R., Hon, Jeremy K., Biakhov, Mikhail Yu, Hingorani, Sunil R., Ganju, Vinod, Weekes, Colin D., Scheithauer, Werner, Ramanathan, Ramesh K., Tabernero, Josep, Goldstein, David, Wei, Xinyu, Romano, Alfredo
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Randomized phase III study of weekly nab -paclitaxel plus gemcitabine versus gemcitabine alone in patients with metastatic adenocarcinoma of the pancreas (MPACT)
Von Hoff, Daniel D., Ervin, Thomas J., Arena, Francis P., Chiorean, E. Gabriela, Infante, Jeffrey R., Moore, Malcolm J., Seay, Thomas E., Tjulandin, Sergei, Ma, Wen Wee, Saleh, Mansoor N., Harris, Marion, Reni, Michele, Ramanathan, Ramesh K., Tabernero, Josep, Hidalgo, Manuel, Van Cutsem, Eric, Goldstein, David, Wei, Xinyu, Iglesias, Jose Luis, Renschler, Markus Frederic
Published in Journal of clinical oncology (01.02.2013)
Published in Journal of clinical oncology (01.02.2013)
Get full text
Journal Article
Phase I-II trial of high-dose epirubicin in patients with lymphoma
CASE, D. C. JR, GAMS, R, ERVIN, T. J, BOYD, M. A, OLDHAM, F. B
Published in Cancer research (Chicago, Ill.) (01.12.1987)
Get full text
Published in Cancer research (Chicago, Ill.) (01.12.1987)
Journal Article
Phenotypic heterogeneity in cultured human head and neck squamous cell carcinoma lines with low-level methotrexate resistance
ROSOWSKY, A, WRIGHT, J. E, CUCCHI, C. A, LIPPKE, J. A, TANTRAVAHI, R, ERVIN, T. J, FREI, E. III
Published in Cancer research (Chicago, Ill.) (01.12.1985)
Get full text
Published in Cancer research (Chicago, Ill.) (01.12.1985)
Journal Article
Results of High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Acute Myeloid Leukemia
Ault, Kenneth A., Case, Delvyn Caedren, Boyd, Marjorie A., Ervin, Thomas J., Aronson, Frederick, Ebrahim, Kurt S., Hedlund, Jacquelyn A.
Published in Blood (16.11.2006)
Published in Blood (16.11.2006)
Get full text
Journal Article